MSX — Miro Sciences Share Price
Last trade - 00:00- AU$19.49m
- AU$14.94m
- AU$0.63m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.32 | ||
| Price to Tang. Book | 4.29 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 30.96 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -31.58% | ||
| Return on Equity | -29.68% | ||
| Operating Margin | -745.07% | ||
Financial Summary
| Year End 30th Jun | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 0.07 | 5.06 | 2.39 | 0.17 | 0.63 | n/a | n/a | -9.66% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Miro Sciences Ltd, formerly NeuroScientific Biopharmaceuticals Limited, is an Australia-based biotechnology company. The Company is focused on developing novel technologies targeted at immune-mediated inflammatory diseases with stem cell science. It has been developing solutions to address complex medical needs where current treatment options are limited or ineffective. Its StemSmart platform is a patented mesenchymal stem cell technology targeting immune-mediated inflammatory disorders, including refractory Crohn's disease. It is designed to regulate immune responses and reduce inflammation in affected tissues. The Company also develops EmtinB, a peptide-based therapeutic candidate targeting optic nerve diseases, including glaucoma. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-II, which is produced as part of the human body's innate immune response to cell injury.
Directors
- Last Annual
- June 30th, 2026
- Last Interim
- June 30th, 2026
- Incorporated
- November 14th, 2002
- Public Since
- July 27th, 2018
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 389,718,547
- Address
- Level 4, 216 St Georges Terrace, PERTH, 6000
- Web
- https://neuroscientific.com
- Phone
- +61 862682641
- Auditors
- Nexia Perth Audit Services Pty Ltd
Latest News for MSX
Upcoming Events for MSX
NeuroScientific Biopharmaceuticals Ltd Annual Shareholders Meeting
Half Year 2027 NeuroScientific Biopharmaceuticals Ltd Earnings Release
Similar to MSX
Actinogen Medical
Australian Stock Exchange - SEATS
Adalta
Australian Stock Exchange - SEATS
Algorae Pharmaceuticals
Australian Stock Exchange - SEATS
Alterity Therapeutics
Australian Stock Exchange - SEATS
Amplia Therapeutics
Australian Stock Exchange - SEATS
FAQ
As of Today at 03:08 UTC, shares in Miro Sciences are trading at AU$0.05. This share price information is delayed by 15 minutes.
Shares in Miro Sciences last closed at AU$0.05 and the price had moved by -50% over the past 365 days. In terms of relative price strength the Miro Sciences share price has underperformed the ASX All Ordinaries Index by -49.15% over the past year.
There is no consensus recommendation for this security.
Find out moreMiro Sciences does not currently pay a dividend.
Miro Sciences does not currently pay a dividend.
Miro Sciences does not currently pay a dividend.
To buy shares in Miro Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.05, shares in Miro Sciences had a market capitalisation of AU$19.49m.
Here are the trading details for Miro Sciences:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: MSX
Based on an overall assessment of its quality, value and momentum Miro Sciences is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Miro Sciences is AU$0.43. That is 760% above the last closing price of AU$0.05.
Analysts covering Miro Sciences currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Miro Sciences. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -52.92%.
As of the last closing price of AU$0.05, shares in Miro Sciences were trading -41.96% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Miro Sciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Miro Sciences' management team is headed by:
- Paul Rennie - NEC
- Matthew Liddelow - CEO
- Abby Macnish Niven - CFO
- Anton Uvarov - EDR
- Stephen Quantrill - NED